Point72 Asia (Singapore) Pte. Ltd. Xencor Inc Transaction History
Point72 Asia (Singapore) Pte. Ltd.
- $480 Billion
- Q2 2024
A detailed history of Point72 Asia (Singapore) Pte. Ltd. transactions in Xencor Inc stock. As of the latest transaction made, Point72 Asia (Singapore) Pte. Ltd. holds 11,207 shares of XNCR stock, worth $226,941. This represents 0.04% of its overall portfolio holdings.
Number of Shares
11,207Holding current value
$226,941% of portfolio
0.04%Shares
2 transactions
Others Institutions Holding XNCR
# of Institutions
204Shares Held
63.1MCall Options Held
3.9KPut Options Held
3K-
Black Rock Inc. New York, NY11.1MShares$225 Million0.0% of portfolio
-
Primecap Management CO Pasadena, CA9.12MShares$185 Million0.13% of portfolio
-
Vanguard Group Inc Valley Forge, PA7MShares$142 Million0.0% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA5.33MShares$108 Million3.57% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.96MShares$80.2 Million0.01% of portfolio
About Xencor Inc
- Ticker XNCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,698,100
- Market Cap $1.21B
- Description
- Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that targets the SARS-CoV-2 virus; Ultomiris for the treatment of patients with paroxysmal nocturnal ...